Pär Stattin

Fosfomycin versus ciprofloxacin for transrectal prostate biopsy: An open randomised controlled multicentre drug trial

Andreasson, Anders; Hällgren, Anita; Georgeoulas, Petros; Forsberg, Jon et al.

Ingår i The Journal of Clinical Urology, s. 170-177, 2026

• DOI för Fosfomycin versus ciprofloxacin for transrectal prostate biopsy: An open randomised controlled multicentre drug trial
• Ladda ner fulltext (pdf) av Fosfomycin versus ciprofloxacin for transrectal prostate biopsy: An open randomised controlled multicentre drug trial

Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Westerberg, Marcus; Gedeborg, Rolf; Garmo, Hans; Jäderling, Fredrik et al.

Ingår i BJUI Compass, 2026

• DOI för Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis
• Ladda ner fulltext (pdf) av Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Ventimiglia, Eugenio; Westerberg, Marcus; Wilberg Orrason, Andri; Ahlberg, Mats et al.

Ingår i European Urology Open Science, s. 72-76, 2026

• DOI för Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study
• Ladda ner fulltext (pdf) av Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy

Scilipoti, Pietro; Callenmark, Max; Garmo, Hans; Stattin, Pär et al.

Ingår i European Urology Open Science, s. 1-9, 2026

• DOI för Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy
• Ladda ner fulltext (pdf) av Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy

Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality

Ventimiglia, Eugenio; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i Acta Oncologica, s. 297-300, 2026

• DOI för Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality
• Ladda ner fulltext (pdf) av Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality

Fosfomycin versus ciprofloxacin for transrectal prostate biopsy: An open randomised controlled multicentre drug trial

Andreasson, Anders; Hällgren, Anita; Georgeoulas, Petros; Forsberg, Jon et al.

Ingår i The Journal of Clinical Urology, s. 170-177, 2026

• DOI för Fosfomycin versus ciprofloxacin for transrectal prostate biopsy: An open randomised controlled multicentre drug trial
• Ladda ner fulltext (pdf) av Fosfomycin versus ciprofloxacin for transrectal prostate biopsy: An open randomised controlled multicentre drug trial

Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Westerberg, Marcus; Gedeborg, Rolf; Garmo, Hans; Jäderling, Fredrik et al.

Ingår i BJUI Compass, 2026

• DOI för Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis
• Ladda ner fulltext (pdf) av Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Ventimiglia, Eugenio; Westerberg, Marcus; Wilberg Orrason, Andri; Ahlberg, Mats et al.

Ingår i European Urology Open Science, s. 72-76, 2026

• DOI för Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study
• Ladda ner fulltext (pdf) av Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy

Scilipoti, Pietro; Callenmark, Max; Garmo, Hans; Stattin, Pär et al.

Ingår i European Urology Open Science, s. 1-9, 2026

• DOI för Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy
• Ladda ner fulltext (pdf) av Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy

Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality

Ventimiglia, Eugenio; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i Acta Oncologica, s. 297-300, 2026

• DOI för Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality
• Ladda ner fulltext (pdf) av Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality

Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

Galdieri, Armando; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i Acta Oncologica, s. 282-288, 2026

• DOI för Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden
• Ladda ner fulltext (pdf) av Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

Survival after spinal surgery for metastases in men with castration-sensitive vs castration-resistant prostate cancer: a nationwide register-based study

Wanman, Johan; Farhang, Mehdy; Nystrom, Helena; Styrke, Johan et al.

Ingår i Scientific Reports, 2026

• DOI för Survival after spinal surgery for metastases in men with castration-sensitive vs castration-resistant prostate cancer: a nationwide register-based study
• Ladda ner fulltext (pdf) av Survival after spinal surgery for metastases in men with castration-sensitive vs castration-resistant prostate cancer: a nationwide register-based study

Survival after spinal surgery for metastases in men with castration-sensitive vs castration-resistant prostate cancer: a nationwide register-based study

Wanman, Johan; Farhang, Mehdy; Nyström, Helena; Styrke, Johan et al.

Ingår i Scientific Reports, 2026

• DOI för Survival after spinal surgery for metastases in men with castration-sensitive vs castration-resistant prostate cancer: a nationwide register-based study
• Ladda ner fulltext (pdf) av Survival after spinal surgery for metastases in men with castration-sensitive vs castration-resistant prostate cancer: a nationwide register-based study

Number of risk factors versus infection after transrectal prostate biopsy: a nationwide population-based study

Örtegren, Joakim; Elvstam, Olof; Kohestani, Kimia; Kjölhede, Henrik et al.

Ingår i Scandinavian journal of urology, s. 99-105, 2026

• DOI för Number of risk factors versus infection after transrectal prostate biopsy: a nationwide population-based study
• Ladda ner fulltext (pdf) av Number of risk factors versus infection after transrectal prostate biopsy: a nationwide population-based study

Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy results

Ventimiglia, Eugenio; Gedeborg, Rolf; Westerberg, Marcus; Zaurito, Paolo et al.

Ingår i Scandinavian journal of urology, s. 64-71, 2026

• DOI för Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy results
• Ladda ner fulltext (pdf) av Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy results

Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study

Zaurito, Paolo; Gedeborg, Rolf; Garmo, Hans; Ventimiglia, Eugenio et al.

Ingår i Scandinavian journal of urology, s. 51-57, 2026

• DOI för Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study
• Ladda ner fulltext (pdf) av Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study

Risk of infectious complications after transperineal prostate biopsy compared to transrectal biopsy: nationwide population-based cohort study in Sweden

Bonnedahl, Jesper; Lundstrom, Karl-Johan; Lampa, Erik; Robinson, David et al.

Ingår i Scandinavian journal of urology, s. 44-50, 2026

• DOI för Risk of infectious complications after transperineal prostate biopsy compared to transrectal biopsy: nationwide population-based cohort study in Sweden
• Ladda ner fulltext (pdf) av Risk of infectious complications after transperineal prostate biopsy compared to transrectal biopsy: nationwide population-based cohort study in Sweden

Prostate cancer characteristics in fathers and risk of early onset high-risk prostate cancer in sons

Lin, E.; Garmo, Hans; Beckmann, Kerri; Bratt, Ola et al.

Ingår i International Journal of Cancer, s. 977-983, 2026

• DOI för Prostate cancer characteristics in fathers and risk of early onset high-risk prostate cancer in sons
• Ladda ner fulltext (pdf) av Prostate cancer characteristics in fathers and risk of early onset high-risk prostate cancer in sons

Urinary tract events after radical radiotherapy (RT) for prostate cancer according to pre-RT International Prostate Symptom Score

Zaurito, Paolo; Westerberg, Marcus; Garmo, Hans; Gedeborg, Rolf et al.

Ingår i BJU International, s. 103-111, 2026

• DOI för Urinary tract events after radical radiotherapy (RT) for prostate cancer according to pre-RT International Prostate Symptom Score
• Ladda ner fulltext (pdf) av Urinary tract events after radical radiotherapy (RT) for prostate cancer according to pre-RT International Prostate Symptom Score

Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study

Zaurito, Paolo; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i BJU International, s. 629-638, 2026

• DOI för Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study
• Ladda ner fulltext (pdf) av Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study

Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC

Persson, Astrid E.; Kjellén, Elisabeth; Garmo, Hans; Adrian, Gabriel et al.

Ingår i Radiotherapy and Oncology, 2026

• DOI för Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC
• Ladda ner fulltext (pdf) av Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC

Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study

Zaurito, Paolo; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i Scandinavian journal of urology, s. 93-96, 2025

• DOI för Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study
• Ladda ner fulltext (pdf) av Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study

Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Scilipoti, Pietro; Garmo, Hans; Gedeborg, Rolf; Robinson, David et al.

Ingår i Journal of the National Cancer Institute, s. 1142-1150, 2025

• DOI för Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study
• Ladda ner fulltext (pdf) av Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer

Ventimiglia, Eugenio; Gedeborg, Rolf; Orrason, Andri Wilberg; Zaurito, Paolo et al.

Ingår i Scandinavian journal of urology, s. 105-107, 2025

• DOI för A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer
• Ladda ner fulltext (pdf) av A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer

Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countries

George, G.; Enting, D.; Garmo, Hans; Stattin, Pär et al.

Ingår i ESMO Real World Data and Digital Oncology, 2025

• DOI för Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countries
• Ladda ner fulltext (pdf) av Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countries

Investigation into the clinical features, treatment patterns, and survival of older men with prostate cancer in Sweden and Belgium

George, G.; Axelson, A. B.; Decaestecker, K.; Garmo, H. et al.

Ingår i ESMO Real World Data and Digital Oncology, 2025

• DOI för Investigation into the clinical features, treatment patterns, and survival of older men with prostate cancer in Sweden and Belgium
• Ladda ner fulltext (pdf) av Investigation into the clinical features, treatment patterns, and survival of older men with prostate cancer in Sweden and Belgium

Associations Between Prostate Cancer and Dementia: A Nationwide Study in Sweden

Crump, Casey; Stattin, Pär; Brooks, James D.; Sundquist, Jan et al.

Ingår i European Urology Oncology, s. 857-865, 2025

• DOI för Associations Between Prostate Cancer and Dementia: A Nationwide Study in Sweden

Patient-and Procedure-specific Risk Factors for Urinary Incontinence After Robot-assisted Radical Prostatectomy: A Nationwide, Population-based Study

Koss Modig, Katarina; Arnsrud Godtman, Rebecka; Carlsson, Stefan; Stattin, Pär et al.

Ingår i European Urology Oncology, s. 932-940, 2025

• DOI för Patient-and Procedure-specific Risk Factors for Urinary Incontinence After Robot-assisted Radical Prostatectomy: A Nationwide, Population-based Study
• Ladda ner fulltext (pdf) av Patient-and Procedure-specific Risk Factors for Urinary Incontinence After Robot-assisted Radical Prostatectomy: A Nationwide, Population-based Study

Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden

Lin, E; Garmo, Hans; Beckmann, Kerri; Bratt, Ola et al.

Ingår i Cancer Epidemiology, Biomarkers and Prevention, s. 1585-1592, 2025

• DOI för Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden
• Ladda ner fulltext (pdf) av Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden

Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer

Westerberg, Marcus; Garmo, Hans; Bonnedahl, Jesper; Eriksson, Marie Hjälm et al.

Ingår i Scientific Reports, 2025

• DOI för Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer
• Ladda ner fulltext (pdf) av Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer

Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase

Westerberg, Marcus; Holm, Lennart; Garmo, Hans; Stattin, Pär et al.

Ingår i International Journal of Epidemiology, 2025

• DOI för Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase
• Ladda ner fulltext (pdf) av Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase

Potential gains from radical treatment of men with prostate cancer according to life expectancy

Irenaeus, Sandra; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i BJUI Compass, 2025

• DOI för Potential gains from radical treatment of men with prostate cancer according to life expectancy
• Ladda ner fulltext (pdf) av Potential gains from radical treatment of men with prostate cancer according to life expectancy

Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study

Zelic, Renata; Westerberg, Marcus; Stattin, Pär; Garmo, Hans et al.

Ingår i European Urology Open Science, s. 41-50, 2025

• DOI för Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study
• Ladda ner fulltext (pdf) av Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study

Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Scilipoti, Pietro; Bratt, Ola; Garmo, Hans; Wilberg Orrason, Andri et al.

Ingår i The Journal of the National Comprehensive Cancer Network, 2025

• DOI för Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity

Strömberg, Ulf; Bonander, Carl; Garmo, Hans; Lambe, Mats et al.

Ingår i Acta Oncologica, s. 677-684, 2025

• DOI för Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity
• Ladda ner fulltext (pdf) av Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity

Gleason scores provide more accurate prognostic information than grade groups

Egevad, Lars; Micoli, Chiara; Delahunt, Brett; Samaratunga, Hemamali et al.

Ingår i Pathology, s. 293-296, 2025

• DOI för Gleason scores provide more accurate prognostic information than grade groups
• Ladda ner fulltext (pdf) av Gleason scores provide more accurate prognostic information than grade groups

Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in Sweden

Westerberg, Marcus; Garmo, H.; Ludvigsson, Jonas; Stattin, Pär et al.

Ingår i Clinical Epidemiology, s. 983-993, 2025

• DOI för Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in Sweden
• Ladda ner fulltext (pdf) av Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in Sweden

Association of height, BMI, and smoking status with prostate cancer risk before and after the introduction of PSA testing in Sweden

Mboya, Innocent B.; Fritz, Josef; Scilipoti, Pietro; Haggstrom, Christel et al.

Ingår i Scientific Reports, 2025

• DOI för Association of height, BMI, and smoking status with prostate cancer risk before and after the introduction of PSA testing in Sweden
• Ladda ner fulltext (pdf) av Association of height, BMI, and smoking status with prostate cancer risk before and after the introduction of PSA testing in Sweden

Time trends in Gleason score distribution among Gleason score 8 and 9-10 cancers

Egevad, Lars; Micoli, Chiara; Delahunt, Brett; Samaratunga, Hemamali et al.

Ingår i Journal of Clinical Pathology, s. 429-431, 2025

• DOI för Time trends in Gleason score distribution among Gleason score 8 and 9-10 cancers

Radical Treatment for Prostate Cancer in Men With Limited Life Expectancy in Sweden

Ventimiglia, Eugenio; Gedeborg, Rolf; Styrke, Johan; Wilberg Orrason, Andri et al.

Ingår i JAMA Network Open, 2025

• DOI för Radical Treatment for Prostate Cancer in Men With Limited Life Expectancy in Sweden
• Ladda ner fulltext (pdf) av Radical Treatment for Prostate Cancer in Men With Limited Life Expectancy in Sweden

Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance

Corsini, Christian; Scilipoti, Pietro; Orrason, Andri Wilberg; Gedeborg, Rolf et al.

Ingår i JNCI Cancer Spectrum, 2025

• DOI för Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance
• Ladda ner fulltext (pdf) av Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance

Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 – a case control study

Ahlberg, Mats Steinholtz; Garmo, Hans; Stattin, Pär; Gedeborg, Rolf et al.

Ingår i Scandinavian journal of urology, s. 63-69, 2024

• DOI för Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 – a case control study
• Ladda ner fulltext (pdf) av Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 – a case control study

A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer

Srinivasan, Srilakshmi; Kryza, Thomas; Bock, Nathalie; Tse, Brian W C et al.

Ingår i Nature Communications, 2024

• DOI för A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer

Prostatacancerregistret: för patienter, sjukvård och forskning

Franck Lissbrant, Ingela; Styrke, Johan; Törnblom, Magnus; Hjelm Eriksson, Marie et al.

Ingår i Läkartidningen, 2024

Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial

Westerberg, Marcus; Garmo, Hans; Robinson, David; Stattin, Pär et al.

Ingår i Journal of Clinical Epidemiology, 2024

• DOI för Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial
• Ladda ner fulltext (pdf) av Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial

Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study

Egevad, Lars; Micoli, Chiara; Delahunt, Brett; Samaratunga, Hemamali et al.

Ingår i Virchows Archiv, s. 995-1003, 2024

• DOI för Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study
• Ladda ner fulltext (pdf) av Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study

Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study

Scilipoti, Pietro; Liedberg, Fredrik; Garmo, Hans; Wilberg Orrason, Andri et al.

Ingår i Scandinavian journal of urology, s. 98-103, 2024

• DOI för Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study
• Ladda ner fulltext (pdf) av Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study

Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Westerberg, Marcus; Irenaeus, Sandra; Garmo, Hans; Stattin, Pär et al.

Ingår i PLOS ONE, 2024

• DOI för Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study
• Ladda ner fulltext (pdf) av Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study

Corsini, Christian; Bergengren, Oskar; Carlsson, Stefan; Garmo, Hans et al.

Ingår i European Urology Oncology, s. 605-613, 2024

• DOI för Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study

Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study

Egevad, Lars; Micoli, Chiara; Samaratunga, Hemamali; Delahunt, Brett et al.

Ingår i European Urology Oncology, s. 213-221, 2024

• DOI för Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study
• Ladda ner fulltext (pdf) av Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study

Population-based study of disease trajectory after radical treatment for high-risk prostate cancer

Stattin, Pär; Fleming, Sarah; Lin, Xiwu; Lefresne, Florence et al.

Ingår i BJU International, s. 96-102, 2024

• DOI för Population-based study of disease trajectory after radical treatment for high-risk prostate cancer
• Ladda ner fulltext (pdf) av Population-based study of disease trajectory after radical treatment for high-risk prostate cancer

Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting

Ventimiglia, Eugenio; Gedeborg, Rolf; Styrke, Johan; Robinson, David et al.

Ingår i JAMA Network Open, 2024

• DOI för Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting
• Ladda ner fulltext (pdf) av Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting

How to improve cancer care by use of guidelines and quality registers

Stattin, Pär

Ingår i Scandinavian journal of urology, s. 190-192, 2024

• DOI för How to improve cancer care by use of guidelines and quality registers
• Ladda ner fulltext (pdf) av How to improve cancer care by use of guidelines and quality registers

Socioeconomic inequality in prostate cancer diagnostics, primary treatment, rehabilitation, and mortality in Sweden

Strömberg, Ulf; Berglund, Anders; Carlsson, Stefan; Thellenberg Karlsson, Camilla et al.

Ingår i International Journal of Cancer, s. 637-645, 2024

• DOI för Socioeconomic inequality in prostate cancer diagnostics, primary treatment, rehabilitation, and mortality in Sweden
• Ladda ner fulltext (pdf) av Socioeconomic inequality in prostate cancer diagnostics, primary treatment, rehabilitation, and mortality in Sweden

Risk of anxiety disorders in men with prostate cancer: a national cohort study

Crump, Casey; Stattin, Pär; Brooks, James D.; Sundquist, Jan et al.

Ingår i JNCI Cancer Spectrum, 2024

• DOI för Risk of anxiety disorders in men with prostate cancer: a national cohort study
• Ladda ner fulltext (pdf) av Risk of anxiety disorders in men with prostate cancer: a national cohort study

Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer

Thomsen, Frederik F.; Garmo, Hans; Egevad, Lars; Stattin, Pär et al.

Ingår i Scandinavian journal of urology, s. 76-83, 2024

• DOI för Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer
• Ladda ner fulltext (pdf) av Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer

Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts

Fritz, Josef; Jochems, Sylvia H. J.; Bjorge, Tone; Wood, Angela M. et al.

Ingår i British Journal of Cancer, s. 308-316, 2024

• DOI för Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts
• Ladda ner fulltext (pdf) av Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts

Risks of depression, anxiety, and suicide in partners of men with prostate cancer: a national cohort study

Crump, Casey; Stattin, Pär; Brooks, James D.; Sundquist, Jan et al.

Ingår i Journal of the National Cancer Institute, s. 745-752, 2024

• DOI för Risks of depression, anxiety, and suicide in partners of men with prostate cancer: a national cohort study

Time trends for the use of active surveillance and deferred treatment for localised prostate cancer in Sweden: a nationwide study

Maljkovic, Jovana; Bill-Axelson, Anna; Hållberg, Hampus; Berglund, Anders et al.

Ingår i Scandinavian journal of urology, s. 200-206, 2024

• DOI för Time trends for the use of active surveillance and deferred treatment for localised prostate cancer in Sweden: a nationwide study
• Ladda ner fulltext (pdf) av Time trends for the use of active surveillance and deferred treatment for localised prostate cancer in Sweden: a nationwide study

Response to Lao, Guan, Wang, et al.

Crump, Casey; Stattin, Pär; Brooks, James D.; Sundquist, Jan et al.

Ingår i Journal of the National Cancer Institute, s. 770-770, 2024

• DOI för Response to Lao, Guan, Wang, et al.

Mortality Risks Associated with Depression in Men with Prostate Cancer

Crump, Casey; Stattin, Pär; Brooks, James D; Sundquist, Jan et al.

Ingår i European Urology Oncology, s. 1411-1419, 2024

• DOI för Mortality Risks Associated with Depression in Men with Prostate Cancer

Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden: the Obesity and Disease Development Sweden (ODDS) pooled cohort study

Sun, Ming; da Silva, Marisa; Bjorge, Tone; Fritz, Josef et al.

Ingår i The Lancet Regional Health, 2024

• DOI för Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden: the Obesity and Disease Development Sweden (ODDS) pooled cohort study
• Ladda ner fulltext (pdf) av Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden: the Obesity and Disease Development Sweden (ODDS) pooled cohort study

Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging.

Robinson, David; Abdulkareem, Rafid; Nasrollah, Delshad; Ljung, Anders et al.

Ingår i JAMA Network Open, 2023

• DOI för Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging.

Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Corsini, Christian; Garmo, Hans; Wilberg Orrason, Andri; Gedeborg, Rolf et al.

Ingår i JAMA Network Open, 2023

• DOI för Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy
• Ladda ner fulltext (pdf) av Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists

Bonde, Tiago M.; Garmo, Hans; Stattin, Pär; Nilsson, Per et al.

Ingår i Acta Oncologica, s. 1815-1821, 2023

• DOI för Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists
• Ladda ner fulltext (pdf) av Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists

Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden

Wilberg Orrason, Andri; Styrke, Johan; Garmo, Hans; Stattin, Pär

Ingår i BJU International, s. 486-493, 2023

• DOI för Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden
• Ladda ner fulltext (pdf) av Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden

Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Gedeborg, Rolf; Sandin, Fredrik; Thellenberg-Karlsson, Camilla; Styrke, Johan et al.

Ingår i Scandinavian journal of urology, s. 93-100, 2023

• DOI för Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden
• Ladda ner fulltext (pdf) av Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

Lin, E.; Garmo, Hans; Hagström, Emil; Van Hemelrijck, Mieke et al.

Ingår i British Journal of Cancer, s. 814-824, 2023

• DOI för Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden
• Ladda ner fulltext (pdf) av Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort study

Crump, Casey; Stattin, Pär; Brooks, James D.; Sundquist, Jan et al.

Ingår i JNCI Cancer Spectrum, 2023

• DOI för Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort study
• Ladda ner fulltext (pdf) av Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort study

Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study

Jochems, Sylvia H. J.; Fritz, Josef; Häggström, Christel; Jarvholm, Bengt et al.

Ingår i European Urology, s. 422-431, 2023

• DOI för Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study
• Ladda ner fulltext (pdf) av Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study

Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study

Jochems, Sylvia H. J.; Fritz, Josef; Häggström, Christel; Stattin, Pär et al.

Ingår i Cancer Medicine, s. 13732-13744, 2023

• DOI för Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study
• Ladda ner fulltext (pdf) av Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study

Thanks and good bye Taylor & Francis, authors and readers see you at Scand J Urol's new website!

Stattin, Pär

Ingår i Scandinavian journal of urology, s. 1-1, 2023

• DOI för Thanks and good bye Taylor & Francis, authors and readers see you at Scand J Urol's new website!

Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

Watts, Eleanor L.; Perez-Cornago, Aurora; Fensom, Georgina K.; Smith-Byrne, Karl et al.

Ingår i International Journal of Epidemiology, s. 71-86, 2023

• DOI för Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis
• Ladda ner fulltext (pdf) av Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

Welcome to the new Scandinavian Journal of Urology!

Stattin, Pär

Ingår i Scandinavian journal of urology, 2023

• DOI för Welcome to the new Scandinavian Journal of Urology!
• Ladda ner fulltext (pdf) av Welcome to the new Scandinavian Journal of Urology!

Stora regionala skillnader i behandlingen av prostatacancer

Stattin, Pär; Gedeborg, Rolf

Ingår i Läkartidningen, 2023

Long-term Risks of Depression and Suicide Among Men with Prostate Cancer: A National Cohort Study

Crump, Casey; Stattin, Pär; Brooks, James D.; Sundquist, Jan et al.

Ingår i European Urology, s. 263-272, 2023

• DOI för Long-term Risks of Depression and Suicide Among Men with Prostate Cancer: A National Cohort Study

Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study.

Shore, Richard; Zhang, Ji; Ye, Weimin; Stattin, Pär et al.

Ingår i Cancer Causes and Control, s. 949-961, 2023

• DOI för Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study.
• Ladda ner fulltext (pdf) av Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study.

Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden.

George, Gincy; Garmo, Hans; Adolfsson, Jan; Elf, Kristin et al.

Ingår i Journal of Oncology, s. 9527920, 2023

• DOI för Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden.

Design considerations for observational studies of drugs for advanced cancer

Garcia-Albeniz, Xabier; Stattin, Pär; Westerberg, Marcus; Weinrib, Rachel et al.

Ingår i Pharmacoepidemiology and Drug Safety, s. 812-815, 2023

• DOI för Design considerations for observational studies of drugs for advanced cancer
• Ladda ner fulltext (pdf) av Design considerations for observational studies of drugs for advanced cancer

Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study

Sun, Ming; Fritz, Josef; Häggström, Christel; Bjørge, Tone et al.

Ingår i Journal of the National Cancer Institute, s. 456-467, 2023

• DOI för Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study
• Ladda ner fulltext (pdf) av Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study

Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

Westerberg, Marcus; Beckmann, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.

Ingår i Journal of Clinical Epidemiology, s. 22-30, 2023

• DOI för Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.
• Ladda ner fulltext (pdf) av Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden

Stattin, Pär; Westerberg, Marcus; Lissbrant, Ingela Franck; Eriksson, Marie Hjälm et al.

Ingår i Clinical Genitourinary Cancer, s. 1070-107000000000, 2023

• DOI för Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden
• Ladda ner fulltext (pdf) av Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden

Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy

Wilberg Orrason, Andri; Westerberg, Marcus; Albertsen, Peter; Styrke, Johan et al.

Ingår i PLOS ONE, 2022

• DOI för Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy
• Ladda ner fulltext (pdf) av Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy

Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Bonde, Tiago M.; Westerberg, Marcus; Aly, Markus; Eklund, Martin et al.

Ingår i Scandinavian journal of urology, s. 169-175, 2022

• DOI för Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists
• Ladda ner fulltext (pdf) av Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

Ventimiglia, Eugenio; Bill-Axelson, Anna; Adolfsson, Jan; Aly, Markus et al.

Ingår i European Urology Open Science, s. 46-51, 2022

• DOI för Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data
• Ladda ner fulltext (pdf) av Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Gedeborg, Rolf; Garmo, Hans; Thellenberg-Karlsson, Camilla; Fallara, Giuseppe et al.

Ingår i Acta Oncologica, s. 328-332, 2022

• DOI för Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden

Ventimiglia, Eugenio; Bill-Axelson, Anna; Bratt, Ola; Montorsi, Francesco et al.

Ingår i JAMA Network Open, 2022

• DOI för Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden
• Ladda ner fulltext (pdf) av Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden

Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy

Gedeborg, Rolf; Loeb, Stacy; Styrke, Johan; Kiiski-Berggren, Ritva et al.

Ingår i International Journal of Cancer, s. 1925-1934, 2022

• DOI för Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy
• Ladda ner fulltext (pdf) av Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy

Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden

Balabanova, Yanina; Farahmand, Bahman; Garmo, Hans; Stattin, Pär et al.

Ingår i BMJ Open, 2022

• DOI för Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden
• Ladda ner fulltext (pdf) av Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden

Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes

Lin, E.; Garmo, Hans; Van Hemelrijck, Mieke; Zethelius, Björn et al.

Ingår i JAMA Network Open, 2022

• DOI för Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes
• Ladda ner fulltext (pdf) av Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes

Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males

Van Hemelrijck, Mieke; Ventimiglia, Eugenio; Robinson, David; Gedeborg, Rolf et al.

Ingår i BMC Medical Informatics and Decision Making, 2022

• DOI för Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males
• Ladda ner fulltext (pdf) av Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males

Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden

Balabanova, Yanina; Farahmand, Bahman; Stattin, Pär; Garmo, Hans et al.

Ingår i BMC Urology, 2022

• DOI för Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden
• Ladda ner fulltext (pdf) av Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden

Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records

Alverbratt, Charlotte; Vikman, Hanna; Eriksson, Marie Hjalm; Stattin, Pär et al.

Ingår i Scandinavian journal of urology, s. 95-101, 2022

• DOI för Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records
• Ladda ner fulltext (pdf) av Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records

Evidence of cancer progression in men with prostate cancer as the adjudicated cause of death

Orrason, Andri Wilberg; Styrke, Johan; Garmo, Hans; Stattin, Pär

Ingår i BJU International, 2022

Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer

Gedeborg, Rolf; Lindhagen, Lars; Loeb, Stacy; Styrke, Johan et al.

Ingår i Scandinavian journal of urology, s. 104-111, 2022

• DOI för Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer
• Ladda ner fulltext (pdf) av Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer

Reply to Paulius Bosas, Gintaras Zaleskis, and Dainius Characiejus's Letter to the Editor re: Sylvia HJ Jochems, Josef Fritz, Christel Haggstrom, Bengt Jarvholm, Par Stattin, Tanja Stocks. Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.033. Therapeutic Monitoring in Prostate Cancer Should Involve a Cotinine Test in Current Smokers

Jochems, Sylvia H. J.; Stattin, Pär; Stocks, Tanja

Ingår i European Urology, 2022

• DOI för Reply to Paulius Bosas, Gintaras Zaleskis, and Dainius Characiejus's Letter to the Editor re: Sylvia HJ Jochems, Josef Fritz, Christel Haggstrom, Bengt Jarvholm, Par Stattin, Tanja Stocks. Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.033. Therapeutic Monitoring in Prostate Cancer Should Involve a Cotinine Test in Current Smokers

Surgeon volume and patient-reported urinary incontinence after radical prostatectomy: Population-based register study in Sweden

Godtman, Rebecka Arnsrud; Persson, Erik; Bergengren, Oskar; Carlsson, Stefan et al.

Ingår i Scandinavian journal of urology, s. 343-350, 2022

• DOI för Surgeon volume and patient-reported urinary incontinence after radical prostatectomy: Population-based register study in Sweden
• Ladda ner fulltext (pdf) av Surgeon volume and patient-reported urinary incontinence after radical prostatectomy: Population-based register study in Sweden

Risk of severe late toxicity after radiotherapy following radical prostatectomy - a nationwide study

Braide, Karin; Kindblom, Jon; Karlsson, Camilla Thellenberg; Stattin, Pär et al.

Ingår i BJU International, s. 799-808, 2022

• DOI för Risk of severe late toxicity after radiotherapy following radical prostatectomy - a nationwide study

Association of Blood Pressure with Prostate Cancer Risk by Disease Severity and Prostate Cancer Death: A Pooled Cohort Study

Jochems, Sylvia H. J.; Häggström, Christel; Stattin, Pär; Järvholm, Bengt et al.

Ingår i Cancer Epidemiology, Biomarkers and Prevention, s. 1483-1491, 2022

• DOI för Association of Blood Pressure with Prostate Cancer Risk by Disease Severity and Prostate Cancer Death: A Pooled Cohort Study

The 90-day cause-specific mortality after radical prostatectomy: a nationwide population-based study.

Björklund, Johan; Stattin, Pär; Rönmark, Erik; Aly, Markus et al.

Ingår i BJU International, s. 318-324, 2022

• DOI för The 90-day cause-specific mortality after radical prostatectomy: a nationwide population-based study.
• Ladda ner fulltext (pdf) av The 90-day cause-specific mortality after radical prostatectomy: a nationwide population-based study.

Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia

Watts, Eleanor L.; Perez-Cornago, Aurora; Fensom, Georgina K.; Smith-Byrne, Karl et al.

Ingår i International Journal of Cancer, s. 1033-1046, 2022

• DOI för Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia
• Ladda ner fulltext (pdf) av Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia

Prostate cancer polygenic risk score and prediction of lethal prostate cancer

Klein, Robert J.; Vertosick, Emily; Sjoberg, Dan; Ulmert, David et al.

Ingår i npj Precision Oncology, 2022

• DOI för Prostate cancer polygenic risk score and prediction of lethal prostate cancer
• Ladda ner fulltext (pdf) av Prostate cancer polygenic risk score and prediction of lethal prostate cancer

Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort

Bergengren, Oskar; Westerberg, Marcus; Holmberg, Lars; Stattin, Pär et al.

Ingår i JAMA Network Open, 2021

• DOI för Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort
• Ladda ner fulltext (pdf) av Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort

Short-term ciprofloxacin prophylaxis for prostate biopsy and risk of aortic aneurysm. Nationwide, population-based cohort study

Lundstrom, Karl-Johan; Garmo, Hans; Gedeborg, Rolf; Stattin, Pär et al.

Ingår i Scandinavian journal of urology, s. 221-226, 2021

• DOI för Short-term ciprofloxacin prophylaxis for prostate biopsy and risk of aortic aneurysm. Nationwide, population-based cohort study

Simulation model of disease incidence driven by diagnostic activity

Westerberg, Marcus; Larsson, Rolf; Holmberg, Lars; Stattin, Pär et al.

Ingår i Statistics in Medicine, s. 1172-1188, 2021

• DOI för Simulation model of disease incidence driven by diagnostic activity
• Ladda ner fulltext (pdf) av Simulation model of disease incidence driven by diagnostic activity

Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden

George, Gincy; Vikman, Hanna; Gedeborg, Rolf; Franck Lissbrant, Ingela et al.

Ingår i Acta Oncologica, s. 459-465, 2021

• DOI för Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden
• Ladda ner fulltext (pdf) av Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden

Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden

Fallara, Giuseppe; Alverbratt, Charlotte; Garmo, Hans; Vikman, Hanna et al.

Ingår i Acta Oncologica, s. 1589-1596, 2021

• DOI för Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden
• Ladda ner fulltext (pdf) av Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden

A drug comorbidity index to predict mortality in men with castration resistant prostate cancer

Fallara, Giuseppe; Gedeborg, Rolf; Bill-Axelson, Anna; Garmo, Hans et al.

Ingår i PLOS ONE, 2021

• DOI för A drug comorbidity index to predict mortality in men with castration resistant prostate cancer
• Ladda ner fulltext (pdf) av A drug comorbidity index to predict mortality in men with castration resistant prostate cancer

Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study

Thomsen, Frederik B; Garmo, Hans; Brasso, Klaus; Egevad, Lars et al.

Ingår i Journal of Surgical Oncology, s. 867-875, 2021

• DOI för Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study
• Ladda ner fulltext (pdf) av Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study

An Aggregated Comorbidity Measure Based on History of Filled Drug Prescriptions: Development and Evaluation in Two Separate Cohorts

Gedeborg, Rolf; Sund, Malin; Lambe, Mats; Plym, Anna et al.

Ingår i Epidemiology, s. 607-615, 2021

• DOI för An Aggregated Comorbidity Measure Based on History of Filled Drug Prescriptions: Development and Evaluation in Two Separate Cohorts

Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.

Gedeborg, Rolf; Styrke, Johan; Loeb, Stacy; Garmo, Hans et al.

Ingår i PLOS ONE, 2021

• DOI för Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.
• Ladda ner fulltext (pdf) av Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.

Waist circumference and a body shape index and prostate cancer risk and mortality

Jochems, Sylvia H. J.; Wood, Angela M.; Häggström, Christel; Orho-Melander, Marju et al.

Ingår i Cancer Medicine, s. 2885-2896, 2021

• DOI för Waist circumference and a body shape index and prostate cancer risk and mortality

A new Editorial Team for the Scandinavian Journal of Urology

Stattin, Pär

Ingår i Scandinavian journal of urology, s. 89-89, 2021

• DOI för A new Editorial Team for the Scandinavian Journal of Urology

Time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer, and its health economic impact: registry-based study in Sweden

Svensson, Johanna; Franck Lissbrant, Ingela; Gauffin, Oskar; Hjälm-Eriksson, Marie et al.

Ingår i Scandinavian journal of urology, s. 1-8, 2021

• DOI för Time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer, and its health economic impact: registry-based study in Sweden
• Ladda ner fulltext (pdf) av Time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer, and its health economic impact: registry-based study in Sweden

Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic

Fallara, Giuseppe; Sandin, Fredrik; Styrke, Johan; Carlsson, Stefan et al.

Ingår i Scandinavian journal of urology, s. 184-191, 2021

• DOI för Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic
• Ladda ner fulltext (pdf) av Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic

Prostate cancer grading, time to go back to the future.

Egevad, Lars; Delahunt, Brett; Bostwick, David G; Cheng, Liang et al.

Ingår i BJU International, s. 165-168, 2021

• DOI för Prostate cancer grading, time to go back to the future.
• Ladda ner fulltext (pdf) av Prostate cancer grading, time to go back to the future.

Association of surgeon and hospital volume with short-term outcomes after robot-assisted radical prostatectomy: Nationwide, population-based study

Godtman, Rebecka Arnsrud; Persson, Erik; Cazzaniga, Walter; Sandin, Fredrik et al.

Ingår i PLOS ONE, 2021

• DOI för Association of surgeon and hospital volume with short-term outcomes after robot-assisted radical prostatectomy: Nationwide, population-based study
• Ladda ner fulltext (pdf) av Association of surgeon and hospital volume with short-term outcomes after robot-assisted radical prostatectomy: Nationwide, population-based study

Androgen Deprivation Therapy and the Risk for Inguinal Hernia: An Observational Nested Case Control Study

Hermann, Maria; Vikman, Hanna; Stattin, Pär; Katawazai, Asmatullah et al.

Ingår i American Journal of Men's Health, 2021

• DOI för Androgen Deprivation Therapy and the Risk for Inguinal Hernia: An Observational Nested Case Control Study
• Ladda ner fulltext (pdf) av Androgen Deprivation Therapy and the Risk for Inguinal Hernia: An Observational Nested Case Control Study

Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study

Lin, E.; Garmo, Hans; Van Hemelrijck, Mieke; Adolfsson, Jan et al.

Ingår i BMC Cancer, 2021

• DOI för Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study
• Ladda ner fulltext (pdf) av Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study

The Inverse Association of Body Mass Index with Lung Cancer: Exploring Residual Confounding, Metabolic Aberrations and Within-Person Variability in Smoking

Wood, Angela M.; Jonsson, Håkan; Nagel, Gabriele; Häggström, Christel et al.

Ingår i Cancer Epidemiology, Biomarkers and Prevention, s. 1489-1497, 2021

• DOI för The Inverse Association of Body Mass Index with Lung Cancer: Exploring Residual Confounding, Metabolic Aberrations and Within-Person Variability in Smoking

Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer

Shore, Richard; Yu, Jingru; Ye, Weimin; Lagergren, Jesper et al.

Ingår i Scientific Reports, 2021

• DOI för Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer
• Ladda ner fulltext (pdf) av Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer

Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project

Nagel, Gabriele; Bjorge, Tone; Jaensch, Andrea; Peter, Raphael S. et al.

Ingår i International Journal of Cancer, s. 66-74, 2021

• DOI för Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project
• Ladda ner fulltext (pdf) av Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project

You can't judge a book by the cover

Stattin, Pär

Ingår i Scandinavian journal of urology, s. 347-347, 2021

• DOI för You can't judge a book by the cover

Rapid ascertainment of uptake of a new indication for abiraterone by use of three nationwide health care registries in Sweden

Fallara, Giuseppe; Lissbrant, Ingela Franck; Styrke, Johan; Montorsi, Francesco et al.

Ingår i Acta Oncologica, s. 56-60, 2021

• DOI för Rapid ascertainment of uptake of a new indication for abiraterone by use of three nationwide health care registries in Sweden

Comparison of Relative Survival and Cause-Specific Survival in Men With Prostate Cancer According to Age and Risk Category: A Nationwide, Population-Based Study.

Wilberg Orrason, Andri; Garmo, Hans; Styrke, Johan; Dickman, Paul W et al.

Ingår i American Journal of Epidemiology, s. 2053-2063, 2021

• DOI för Comparison of Relative Survival and Cause-Specific Survival in Men With Prostate Cancer According to Age and Risk Category: A Nationwide, Population-Based Study.
• Ladda ner fulltext (pdf) av Comparison of Relative Survival and Cause-Specific Survival in Men With Prostate Cancer According to Age and Risk Category: A Nationwide, Population-Based Study.

Epidemiology and Prevention of Prostate Cancer

Gandaglia, Giorgio; Leni, Riccardo; Bray, Freddie; Fleshner, Neil et al.

Ingår i European Urology Oncology, s. 877-892, 2021

• DOI för Epidemiology and Prevention of Prostate Cancer

Reply by Authors

Vertosick, Emily A.; Häggström, Christel; Sjöberg, Daniel D.; Hallmans, Göran et al.

Ingår i Journal of Urology, s. 287-288, 2020

• DOI för Reply by Authors

Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden

Orrason, Andri Wilberg; Westerberg, Marcus; Garmo, Hans; Lissbrant, Ingela Franck et al.

Ingår i BJU International, s. 142-151, 2020

• DOI för Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden
• Ladda ner fulltext (pdf) av Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden

Prescription-based prediction of baseline mortality risk among older men

Gedeborg, Rolf; Garmo, Hans; Robinson, David; Stattin, Pär

Ingår i PLOS ONE, 2020

• DOI för Prescription-based prediction of baseline mortality risk among older men
• Ladda ner fulltext (pdf) av Prescription-based prediction of baseline mortality risk among older men

Opioid Use after Radical Prostatectomy: Nationwide, Population Based Study in Sweden

Loeb, Stacy; Cazzaniga, Walter; Robinson, David; Garmo, Hans et al.

Ingår i Journal of Urology, s. 145-150, 2020

• DOI för Opioid Use after Radical Prostatectomy: Nationwide, Population Based Study in Sweden

Observational study on time on treatment with abiraterone and enzalutamide

Fallara, Giuseppe; Lissbrant, Ingela Franck; Styrke, Johan; Montorsi, Francesco et al.

Ingår i PLOS ONE, 2020

• DOI för Observational study on time on treatment with abiraterone and enzalutamide
• Ladda ner fulltext (pdf) av Observational study on time on treatment with abiraterone and enzalutamide

Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study

Westerberg, Marcus; Franck Lissbrant, Ingela; Damber, Jan Erik; Robinson, David et al.

Ingår i Acta Oncologica, s. 106-111, 2020

• DOI för Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study
• Ladda ner fulltext (pdf) av Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study

5 alpha-Reductase Inhibitors and Risk of Prostate Cancer Death

Miranda, Tiago Bonde; Garmo, Hans; Stattin, Pär; Robinson, David

Ingår i Journal of Urology, s. 714-719, 2020

• DOI för 5 alpha-Reductase Inhibitors and Risk of Prostate Cancer Death

Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort Study

Pettersson, Andreas; Alm, Daniel; Garmo, Hans; Hjelm Eriksson, Marie et al.

Ingår i JNCI Cancer Spectrum, 2020

• DOI för Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort Study
• Ladda ner fulltext (pdf) av Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort Study

Early-Life Cardiorespiratory Fitness and Long-term Risk of Prostate Cancer

Crump, Casey; Stattin, Pär; Brooks, James D.; Stocks, Tanja et al.

Ingår i Cancer Epidemiology, Biomarkers and Prevention, s. 2187-2194, 2020

• DOI för Early-Life Cardiorespiratory Fitness and Long-term Risk of Prostate Cancer

Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey

Stranne, J; Axen, E; Franck-Lissbrant, I; Fransson, P et al.

Ingår i World journal of urology, s. 1397-1411, 2020

• DOI för Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey
• Ladda ner fulltext (pdf) av Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey

Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 Years

Vertosick, Emily A.; Häggström, Christel; Sjoberg, Daniel D.; Hallmans, Goran et al.

Ingår i Journal of Urology, s. 281-287, 2020

• DOI för Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 Years

Current routines for antibiotic prophylaxis prior to transrectal prostate biopsy: a national survey to all urology clinics in Sweden.

Styrke, Johan; Resare, Sven; Lundström, Karl-Johan; Masaba, Patrick et al.

Ingår i F1000 Research, 2020

• DOI för Current routines for antibiotic prophylaxis prior to transrectal prostate biopsy: a national survey to all urology clinics in Sweden.
• Ladda ner fulltext (pdf) av Current routines for antibiotic prophylaxis prior to transrectal prostate biopsy: a national survey to all urology clinics in Sweden.

Long-term adherence to GnRH agonists in men with prostate cancer: A nation-wide population-based study in prostate cancer data base Sweden

George, Gincy; Garmo, Hans; Rudman, Sarah; Holmberg, Lars et al.

Ingår i Scandinavian journal of urology, s. 20-26, 2020

• DOI för Long-term adherence to GnRH agonists in men with prostate cancer: A nation-wide population-based study in prostate cancer data base Sweden
• Ladda ner fulltext (pdf) av Long-term adherence to GnRH agonists in men with prostate cancer: A nation-wide population-based study in prostate cancer data base Sweden

Overall survival and second primary malignancies in men with metastatic prostate cancer

Mehtälä, Juha; Zong, Jihong; Vassilev, Zdravko; Brobert, Gunnar et al.

Ingår i PLOS ONE, 2020

• DOI för Overall survival and second primary malignancies in men with metastatic prostate cancer
• Ladda ner fulltext (pdf) av Overall survival and second primary malignancies in men with metastatic prostate cancer

Set-up and preliminary results from the Patient-overview Prostate Cancer: Longitudinal registration of treatment of advanced prostate cancer in the National Prostate Cancer Register of Sweden

Lissbrant, Ingela Franck; Eriksson, Marie Hjalm; Lambe, Mats; Tornblom, Magnus et al.

Ingår i Scandinavian journal of urology, s. 227-234, 2020

• DOI för Set-up and preliminary results from the Patient-overview Prostate Cancer: Longitudinal registration of treatment of advanced prostate cancer in the National Prostate Cancer Register of Sweden
• Ladda ner fulltext (pdf) av Set-up and preliminary results from the Patient-overview Prostate Cancer: Longitudinal registration of treatment of advanced prostate cancer in the National Prostate Cancer Register of Sweden

Risk of Postoperative Up Staging or Upgrading among Men with Low Risk Familial Prostate Cancer

Jansson, Fredrik; Folkvaljon, Folke; Stattin, Pär; Bratt, Ola et al.

Ingår i Journal of Urology, s. 79-81, 2020

• DOI för Risk of Postoperative Up Staging or Upgrading among Men with Low Risk Familial Prostate Cancer

Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study

Plym, Anna; Clements, Mark; Voss, Margaretha; Holmberg, Lars et al.

Ingår i BMJ Open, 2020

• DOI för Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study
• Ladda ner fulltext (pdf) av Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study

Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016

Beckmann, Kerri; Garmo, Hans; Nilsson, Per; Franck Lissbrant, Ingela et al.

Ingår i Acta Oncologica, s. 549-557, 2020

• DOI för Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016
• Ladda ner fulltext (pdf) av Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016

Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study

Zelic, Renata; Garmo, Hans; Zugna, Daniela; Stattin, Pär et al.

Ingår i European Urology, s. 180-188, 2020

• DOI för Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study

Prostate cancer in kidney transplant recipients - a nationwide register study.

Bratt, Ola; Drevin, Linda; Prütz, Karl-Göran; Carlsson, Stefan et al.

Ingår i BJU International, s. 679-685, 2020

• DOI för Prostate cancer in kidney transplant recipients - a nationwide register study.
• Ladda ner fulltext (pdf) av Prostate cancer in kidney transplant recipients - a nationwide register study.

A nutrient-wide association study for risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition and the Netherlands Cohort Study

Papadimitriou, Nikos; Muller, David; van den Brandt, Piet A.; Geybels, Milan et al.

Ingår i European Journal of Nutrition, s. 2929-2937, 2020

• DOI för A nutrient-wide association study for risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition and the Netherlands Cohort Study
• Ladda ner fulltext (pdf) av A nutrient-wide association study for risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition and the Netherlands Cohort Study

The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers

Fritz, Josef; Bjørge, Tone; Nagel, Gabriele; Manjer, Jonas et al.

Ingår i International Journal of Epidemiology, s. 193-204, 2020

• DOI för The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers

Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study

Lin, E.; Garmo, Hans; Van Hemelrijck, Mieke; Adolfsson, Jan et al.

Ingår i BMC Cancer, 2020

• DOI för Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study
• Ladda ner fulltext (pdf) av Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study

Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study

Parker, Jonathan; Crawley, Danielle; Garmo, Hans; Lindahl, Bertil et al.

Ingår i Frontiers in Oncology, 2020

• DOI för Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study
• Ladda ner fulltext (pdf) av Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study

Comparative performance and external validation of the multivariable PREDICTProstatetool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)

Thurtle, David; Bratt, Ola; Stattin, Pär; Pharoah, Paul et al.

Ingår i BMC Medicine, 2020

• DOI för Comparative performance and external validation of the multivariable PREDICTProstatetool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)
• Ladda ner fulltext (pdf) av Comparative performance and external validation of the multivariable PREDICTProstatetool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)

Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study

Thomsen, Frederik B.; Westerberg, Marcus; Garmo, Hans; Robinson, David et al.

Ingår i PLOS ONE, 2020

• DOI för Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study
• Ladda ner fulltext (pdf) av Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study

Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study

Beckmann, Kerri; Garmo, Hans; Lindahl, Bertil; Holmberg, Lars et al.

Ingår i Prostate Cancer and Prostatic Diseases, s. 527-533, 2020

• DOI för Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study

Linear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk: An internal replication study of 800,000 individuals

Häggström, Christel; Jonsson, Håkan; Björge, Tone; Nagel, Gabriele et al.

Ingår i International Journal of Cancer, s. 58-67, 2020

• DOI för Linear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk: An internal replication study of 800,000 individuals

How to measure temporal changes in care pathways for chronic diseases using health care registry data

Ventimiglia, Eugenio; Van Hemelrijck, Mieke; Lindhagen, Lars; Stattin, Pär et al.

Ingår i BMC Medical Informatics and Decision Making, 2019

• DOI för How to measure temporal changes in care pathways for chronic diseases using health care registry data
• Ladda ner fulltext (pdf) av How to measure temporal changes in care pathways for chronic diseases using health care registry data

Androgen deprivation therapy for prostate cancer and risk of dementia

Robinson, David; Garmo, Hans; Van Hemelrijck, Mieke; Damber, Jan-Erik et al.

Ingår i BJU International, s. 87-92, 2019

• DOI för Androgen deprivation therapy for prostate cancer and risk of dementia
• Ladda ner fulltext (pdf) av Androgen deprivation therapy for prostate cancer and risk of dementia

Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 (SPCG-4) study

Cazzaniga, Walter; Garmo, Hans; Robinson, David; Holmberg, Lars et al.

Ingår i BJU International, s. 421-428, 2019

• DOI för Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 (SPCG-4) study

Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study

Thomsen, Frederik Birkebaek; Bosco, Cecilia; Garmo, Hans; Adolfsson, Jan et al.

Ingår i Acta Oncologica, s. 110-118, 2019

• DOI för Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study
• Ladda ner fulltext (pdf) av Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study

Anastomotic leakage after anterior resection in patients with rectal cancer previously irradiated for prostate cancer

Sverrisson, Ingvar; Folkvaljon, Folke; Chabok, Abbas; Stattin, Pär et al.

Ingår i European Journal of Surgical Oncology, s. 341-346, 2019

• DOI för Anastomotic leakage after anterior resection in patients with rectal cancer previously irradiated for prostate cancer

Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome

Hammarsten, Peter; Josefsson, Andreas; Thysell, Elin; Lundholm, Marie et al.

Ingår i Modern Pathology, s. 1310-1319, 2019

• DOI för Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome
• Ladda ner fulltext (pdf) av Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome

Defining Intermediate Risk Prostate Cancer Suitable for Active Surveillance

Loeb, Stacy; Folkvaljon, Yasin; Bratt, Ola; Robinson, David et al.

Ingår i Journal of Urology, s. 292-299, 2019

• DOI för Defining Intermediate Risk Prostate Cancer Suitable for Active Surveillance

Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate Cancer

Beckmann, Kerri; Garmo, Hans; Adolfsson, Jan; Bosco, Cecilia et al.

Ingår i European Urology, s. 676-683, 2019

• DOI för Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate Cancer

Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer

Gnanapragasam, Vincent J.; Barrett, Tristan; Thankapannair, Vineetha; Thurtle, David et al.

Ingår i BJU International, s. 758-767, 2019

• DOI för Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer

Population-based, nationwide registration of prostatectomies in Sweden

Cazzaniga, Walter; Godtman, Rebecka Arnsrud; Carlsson, Stefan; Ahlgren, Göran et al.

Ingår i Journal of Surgical Oncology, s. 803-812, 2019

• DOI för Population-based, nationwide registration of prostatectomies in Sweden
• Ladda ner fulltext (pdf) av Population-based, nationwide registration of prostatectomies in Sweden

Epidemiology of hydrocele and spermatocele; incidence, treatment and complications

Lundström, Karl-Johan; Söderström, Lars; Jernow, Henning; Stattin, Pär et al.

Ingår i Scandinavian journal of urology, s. 134-138, 2019

• DOI för Epidemiology of hydrocele and spermatocele; incidence, treatment and complications

The Value of an Extensive Transrectal Repeat Biopsy with Anterior Sampling in Men on Active Surveillance for Low-risk Prostate Cancer: A Comparison from the Randomised Study of Active Monitoring in Sweden (SAMS)

Bratt, Ola; Holmberg, Erik; Andren, Ove; Carlsson, Stefan et al.

Ingår i European Urology, s. 461-466, 2019

• DOI för The Value of an Extensive Transrectal Repeat Biopsy with Anterior Sampling in Men on Active Surveillance for Low-risk Prostate Cancer: A Comparison from the Randomised Study of Active Monitoring in Sweden (SAMS)

Prostate cancer induces C/EBP expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome

Adamo, Hanibal; Hammarsten, Peter; Hägglöf, Christina; Scherdin, Tove Dahl et al.

Ingår i The Prostate, s. 435-445, 2019

• DOI för Prostate cancer induces C/EBP expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome

Development and validation of a prediction model for identifying men with intermediate- or high-risk prostate cancer for whom bone imaging is unnecessary: a nation-wide population-based study

Arnsrud Godtman, Rebecka; Månsson, Marianne; Bratt, Ola; Robinsson, David et al.

Ingår i Scandinavian journal of urology, s. 378-384, 2019

• DOI för Development and validation of a prediction model for identifying men with intermediate- or high-risk prostate cancer for whom bone imaging is unnecessary: a nation-wide population-based study

Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study

Beckmann, Kerri; Russell, Beth; Josephs, Debra; Garmo, Hans et al.

Ingår i BMC Cancer, 2019

• DOI för Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study
• Ladda ner fulltext (pdf) av Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study

BMI and weight changes and risk of obesity-related cancers: a pooled European cohort study

Bjørge, Tone; Häggström, Christel; Ghaderi, Sara; Nagel, Gabriele et al.

Ingår i International Journal of Epidemiology, s. 1872-1885, 2019

• DOI för BMI and weight changes and risk of obesity-related cancers: a pooled European cohort study

Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study

Arthur, Rhonda; Møller, Henrik; Garmo, Hans; Häggström, Christel et al.

Ingår i Cancer Causes and Control, s. 195-206, 2019

• DOI för Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study

The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies

Watts, Eleanor L.; Perez-Cornago, Aurora; Appleby, Paul N.; Albanes, Demetrius et al.

Ingår i International Journal of Cancer, s. 3244-3256, 2019

• DOI för The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies
• Ladda ner fulltext (pdf) av The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies

Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor

Thysell, Elin; Vidman, Linda; Ylitalo, Erik Bovinder; Jernberg, Emma et al.

Ingår i Molecular Oncology, s. 1763-1777, 2019

• DOI för Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor
• Ladda ner fulltext (pdf) av Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor

Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus

Häggström, Christel; Van Hemelrijck, Mieke; Garmo, Hans; Robinson, David et al.

Ingår i International Journal of Cancer, s. 1868-1875, 2018

• DOI för Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus
• Ladda ner fulltext (pdf) av Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus

Reply to the letter to the editor 'Age at diagnosis and prognosis among prostate cancer patients treated with radiotherapy: evidenced from three independent cohort studies' by X. Dong, G. Ma and F. Chen

Pettersson, A.; Robinson, D.; Garmo, Hans; Holmberg, Lars et al.

Ingår i Annals of Oncology, s. 2020-2021, 2018

• DOI för Reply to the letter to the editor 'Age at diagnosis and prognosis among prostate cancer patients treated with radiotherapy: evidenced from three independent cohort studies' by X. Dong, G. Ma and F. Chen

Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study

Arthur, R.; Williams, R.; Garmo, Hans; Holmberg, Lars et al.

Ingår i International Journal of Cancer, s. 2254-2262, 2018

• DOI för Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study

Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study

Pettersson, A; Robinson, D; Garmo, H; Holmberg, Lars et al.

Ingår i Annals of Oncology, s. 377-385, 2018

• DOI för Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study

Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening

Assel, Melissa; Dahlin, Anders; Ulmert, David; Bergh, Anders et al.

Ingår i European Urology, s. 961-967, 2018

• DOI för Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening

Concordance of Non-Low-Risk Disease Among Pairs of Brothers With Prostate Cancer

Jansson, Fredrik; Drevin, Linda; Frisell, Thomas; Stattin, Pär et al.

Ingår i Journal of Clinical Oncology, s. 1847-1852, 2018

• DOI för Concordance of Non-Low-Risk Disease Among Pairs of Brothers With Prostate Cancer

Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women

Teleka, Stanley; Häggström, Christel; Nagel, Gabriele; Bjorge, Tone et al.

Ingår i International Journal of Cancer, s. 3071-3082, 2018

• DOI för Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women

Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival

Li, Weiqiang; Middha, Mridu; Bicak, Mesude; Sjoberg, Daniel D. et al.

Ingår i European Urology, s. 710-719, 2018

• DOI för Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival

Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in Sweden

Nugin, Hampus; Folkvaljon, Yasin; Damber, Jan-Erik; Adolfsson, Jan et al.

Ingår i Scandinavian journal of urology, s. 277-284, 2018

• DOI för Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in Sweden

Quality Indicators For Global Benchmarking Of Localized Prostate Cancer Management Editorial Comment

Stattin, Pär

Ingår i Journal of Urology, s. 325-326, 2018

• DOI för Quality Indicators For Global Benchmarking Of Localized Prostate Cancer Management Editorial Comment

Public online reporting from a nationwide population-based clinical prostate cancer register

Stattin, Pär; Sandin, Fredrik; Loeb, Stacy; Robinson, David et al.

Ingår i BJU International, s. 8-10, 2018

• DOI för Public online reporting from a nationwide population-based clinical prostate cancer register
• Ladda ner fulltext (pdf) av Public online reporting from a nationwide population-based clinical prostate cancer register

Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study

Robinson, David; Garmo, Hans; Lissbrant, Ingela Franck; Widmark, Anders et al.

Ingår i European Urology, s. 502-511, 2018

• DOI för Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study
• Ladda ner fulltext (pdf) av Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study

Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies

Watts, Eleanor L.; Appleby, Paul N.; Perez-Cornago, Aurora; Bueno-de-Mesquita, H. Bas et al.

Ingår i European Urology, s. 585-594, 2018

• DOI för Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies
• Ladda ner fulltext (pdf) av Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies

Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden

Lissbrant, Ingela Franck; Ventimiglia, Eugenio; Robinson, David; Törnblom, Magnus et al.

Ingår i Scandinavian journal of urology, s. 143-150, 2018

• DOI för Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden
• Ladda ner fulltext (pdf) av Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden

Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60,000 men and women in Sweden and Austria

Van Hemelrijck, Mieke; Ulmer, Hanno; Nagel, Gabriele; Peter, Raphael Simon et al.

Ingår i PLOS ONE, 2018

• DOI för Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60,000 men and women in Sweden and Austria
• Ladda ner fulltext (pdf) av Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60,000 men and women in Sweden and Austria

Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study

Crawley, Danielle; Garmo, Hans; Rudman, Sarah; Stattin, Pär et al.

Ingår i BMJ Open, 2018

• DOI för Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study
• Ladda ner fulltext (pdf) av Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study

The use of palliative medications before death from prostate cancer: Swedish population-based study with a comparative overview of European data

Lycken, Magdalena; Drevin, Linda; Garmo, Hans; Stattin, Pär et al.

Ingår i European Journal of Cancer, s. 101-108, 2018

• DOI för The use of palliative medications before death from prostate cancer: Swedish population-based study with a comparative overview of European data

The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

Gnanapragasam, V. J.; Bratt, O.; Muir, K.; Lees, L. S. et al.

Ingår i BMC Medicine, 2018

• DOI för The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study
• Ladda ner fulltext (pdf) av The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

Diagnosspecifika översikter är viktiga verktyg för cancervården

Stattin, Pär; Franck Lissbrant, Ingela

Ingår i Läkartidningen, 2018

A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0

Russell, Beth; Garmo, Hans; Beckmann, Kerri; Stattin, Pär et al.

Ingår i PLOS ONE, 2018

• DOI för A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0
• Ladda ner fulltext (pdf) av A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0

Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population-based study

Tomic, Katarina; Ventimiglia, Eugenio; Robinson, David; Häggström, Christel et al.

Ingår i International Journal of Cancer, s. 2478-2484, 2018

• DOI för Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population-based study

Nationwide, population-based study of post radical prostatectomy urinary incontinence correction surgery

Ventimiglia, Eugenio; Folkvaljon, Yasin; Carlsson, Stefan; Bratt, Ola et al.

Ingår i Journal of Surgical Oncology, s. 321-327, 2018

• DOI för Nationwide, population-based study of post radical prostatectomy urinary incontinence correction surgery
• Ladda ner fulltext (pdf) av Nationwide, population-based study of post radical prostatectomy urinary incontinence correction surgery

Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls

Perez-Cornago, Aurora; Appleby, Paul N.; Boeing, Heiner; Gil, Leire et al.

Ingår i International Journal of Cancer, s. 2677-2686, 2018

• DOI för Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls
• Ladda ner fulltext (pdf) av Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls

Drugs for metabolic conditions and prostate cancer death in men on GnRH agonists.

Bosco, Cecilia; Wong, Chloe; Garmo, Hans; Crawley, Danielle et al.

Ingår i BJU International, s. 260-267, 2018

• DOI för Drugs for metabolic conditions and prostate cancer death in men on GnRH agonists.

Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancer.

Crawley, Danielle; Garmo, Hans; Rudman, Sarah; Stattin, Pär et al.

Ingår i BJU International, s. 209-216, 2018

• DOI för Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancer.

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

FitzGerald, L. M.; Zhao, S.; Leonardson, A.; Geybels, M. S. et al.

Ingår i Prostate Cancer and Prostatic Diseases, s. 228-237, 2018

• DOI för Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases
• Ladda ner fulltext (pdf) av Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

No difference in risk of cardiovascular disease in men with prostate cancer treated with GnRH agonists or orchiectomy: semi-ecologic, nationwide, population-based study

Thomsen, Frederik B.; Sandin, Fredrik; Garmo, Hans; Lissbrant, Ingela F. et al.

Ingår i Scandinavian journal of urology, s. 16-16, 2017

• DOI för No difference in risk of cardiovascular disease in men with prostate cancer treated with GnRH agonists or orchiectomy: semi-ecologic, nationwide, population-based study

Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study

Thomsen, Frederik Birkebæk; Sandin, Fredrik; Garmo, Hans; Lissbrant, Ingela Franck et al.

Ingår i European Urology, s. 920-928, 2017

• DOI för Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study
• Ladda ner fulltext (pdf) av Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study

Use of palliative medications before death from prostate cancer: a population based study

Lycken, Magdalena; Drevin, Linda; Garmo, Hans; Stattin, Pär et al.

Ingår i Scandinavian journal of urology, s. 25-26, 2017

• DOI för Use of palliative medications before death from prostate cancer: a population based study

A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor

Licciardello, Marco P.; Ringler, Anna; Markt, Patrick; Klepsch, Freya et al.

Ingår i Nature Chemical Biology, s. 771-778, 2017

• DOI för A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor

Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study

Stattin, Pär; Sandin, Fredrik; Thomsen, Frederik Birkebk; Garmo, Hans et al.

Ingår i European Urology, s. 125-134, 2017

• DOI för Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study
• Ladda ner fulltext (pdf) av Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study

Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012

Danneman, Daniela; Drevin, Linda; Delahunt, Brett; Samaratunga, Hemamali et al.

Ingår i BJU International, s. 50-56, 2017

• DOI för Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012

Re: Adi J. Klil-Drori, Hui Yin, Vicky Tagalakis, Armen Aprikian, Laurent Azoulay. Androgen Deprivation Therapy for Prostate Cancer and Risk of Venous Thromboembolism Eur Urol 2016;70:56-61

Van Hemelrijck, Mieke; Garmo, Hans; Adolfsson, Jan; Stattin, Pär

Ingår i European Urology, 2017

• DOI för Re: Adi J. Klil-Drori, Hui Yin, Vicky Tagalakis, Armen Aprikian, Laurent Azoulay. Androgen Deprivation Therapy for Prostate Cancer and Risk of Venous Thromboembolism Eur Urol 2016;70:56-61

Prognostic Significance of Prostate Cancer with Seminal Vesicle Invasion on Radical Prostatectomy: A National Registry Study

Egevad, Lars; Kristiansen, Anna; Drevin, Linda; Delahunt, Brett et al.

Ingår i Laboratory Investigation, 2017

Associations between prediagnostic blood glucose levels, diabetes, and glioma.

Schwartzbaum, Judith; Edlinger, Michael; Zigmont, Victoria; Stattin, Pär et al.

Ingår i Scientific Reports, 2017

• DOI för Associations between prediagnostic blood glucose levels, diabetes, and glioma.

Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study

Perez-Cornago, Aurora; Appleby, Paul N; Pischon, Tobias; Tsilidis, Konstantinos K et al.

Ingår i BMC Medicine, 2017

• DOI för Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study
• Ladda ner fulltext (pdf) av Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study

Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.

Kristiansen, Anna; Drevin, Linda; Delahunt, Brett; Samaratunga, Hemamali et al.

Ingår i Pathology, s. 715-720, 2017

• DOI för Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.

Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer

Häggström, Christel; Van Hemelrijck, Mieke; Zethelius, Björn; Robinson, David et al.

Ingår i International Journal of Cancer, s. 611-617, 2017

• DOI för Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer
• Ladda ner fulltext (pdf) av Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer

Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.

Watts, Eleanor L; Appleby, Paul N; Albanes, Demetrius; Black, Amanda et al.

Ingår i PLOS ONE, 2017

• DOI för Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.
• Ladda ner fulltext (pdf) av Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.

Long-term adverse effects after retropubic and robot-assisted radical prostatectomy: Nationwide, population-based study

Fridriksson, Jón Örn; Folkvaljon, Yasin; Lundström, Karl-Johan; Robinson, David et al.

Ingår i Journal of Surgical Oncology, s. 500-506, 2017

• DOI för Long-term adverse effects after retropubic and robot-assisted radical prostatectomy: Nationwide, population-based study
• Ladda ner fulltext (pdf) av Long-term adverse effects after retropubic and robot-assisted radical prostatectomy: Nationwide, population-based study

Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden

Loeb, Stacy; Folkvaljon, Yasin; Curnyn, Caitlin; Robinson, David et al.

Ingår i JAMA Oncology, s. 1393-1398, 2017

• DOI för Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden

Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response.

Ylitalo, Erik Bovinder; Thysell, Elin; Jernberg, Emma; Lundholm, Marie et al.

Ingår i European Urology, s. 776-787, 2017

• DOI för Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response.

Kvaliteten på radikal prostatektomi måste säkerställas - Fortlöpande förbättringsarbete behövs på varje klinik: med patientenkäter kan enskilda kirurgers resultat följas upp

Hugosson, j; Stattin, Pär

Ingår i Läkartidningen, 2017

Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer

Van Hemelrijck, Mieke; Garmo, Hans; Lindhagen, Lars; Bratt, Ola et al.

Ingår i European Urology, s. 534-541, 2017

• DOI för Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer
• Ladda ner fulltext (pdf) av Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer

Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy

Adam, Meike; Tennstedt, Pierre; Lanwehr, Dominik; Tilki, Derya et al.

Ingår i European Urology, s. 330-336, 2017

• DOI för Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy

Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE₅Is) and Risk of Melanoma

Loeb, Stacy; Ventimiglia, Eugenio; Salonia, Andrea; Folkvaljon, Yasin et al.

Ingår i Journal of the National Cancer Institute, 2017

• DOI för Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE₅Is) and Risk of Melanoma
• Ladda ner fulltext (pdf) av Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE₅Is) and Risk of Melanoma

Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Perez-Cornago, Aurora; Travis, Ruth C.; Appleby, Paul N.; Tsilidis, Konstantinos K. et al.

Ingår i International Journal of Cancer, s. 287-297, 2017

• DOI för Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)
• Ladda ner fulltext (pdf) av Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events

Bosco, Cecilia; Garmo, Hans; Adolfsson, Jan; Stattin, Pär et al.

Ingår i International Journal of Radiation Oncology, Biology, Physics, s. 1026-1031, 2017

• DOI för Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events
• Ladda ner fulltext (pdf) av Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events

Waiting times for cancer patients in Sweden: A nationwide population-based study

Robertson, Stephanie; Adolfsson, Jan; Stattin, Pär; Sjövall, Annika et al.

Ingår i Scandinavian Journal of Public Health, s. 230-237, 2017

• DOI för Waiting times for cancer patients in Sweden: A nationwide population-based study

Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer

Loeb, Stacy; Folkvaljon, Yasin; Damber, Jan-Erik; Alukal, Joseph et al.

Ingår i Journal of Clinical Oncology, s. 1430-1436, 2017

• DOI för Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer
• Ladda ner fulltext (pdf) av Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer

Reply to Glen Denmer Santok and Koon Ho Rha's Letter to the Editor re: Par Stattin, Fredrik Sandin, Frederik Birkebaek Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.023

Stattin, Pär; Bratt, Ola

Ingår i European Urology, 2017

• DOI för Reply to Glen Denmer Santok and Koon Ho Rha's Letter to the Editor re: Par Stattin, Fredrik Sandin, Frederik Birkebaek Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.023

Prognostic Significance of Prostate Cancer with Seminal Vesicle Invasion on Radical Prostatectomy: A National Registry Study

Egevad, Lars; Kristiansen, Anna; Drevin, Linda; Delahunt, Brett et al.

Ingår i Modern Pathology, 2017

• DOI för Prognostic Significance of Prostate Cancer with Seminal Vesicle Invasion on Radical Prostatectomy: A National Registry Study

Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study

Bratt, Ola; Drevin, Linda; Akre, Olof; Garmo, Hans et al.

Ingår i Journal of the National Cancer Institute, 2016

• DOI för Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study
• Ladda ner fulltext (pdf) av Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study

Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base--a refined prostate cancer trajectory.

Van Hemelrijck, Mieke; Garmo, Hans; Wigertz, Annette; Nilsson, Per et al.

Ingår i International Journal of Epidemiology, s. 73-82, 2016

• DOI för Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base--a refined prostate cancer trajectory.

Causes of death in men with localized prostate cancer: a nationwide, population-based study.

Van Hemelrijck, Mieke; Folkvaljon, Yasin; Adolfsson, Jan; Akre, Olof et al.

Ingår i BJU International, s. 507-514, 2016

• DOI för Causes of death in men with localized prostate cancer: a nationwide, population-based study.
• Ladda ner fulltext (pdf) av Causes of death in men with localized prostate cancer: a nationwide, population-based study.

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer

Crawley, Danielle; Garmo, Hans; Rudman, Sarah; Stattin, Pär et al.

Ingår i International Journal of Cancer, s. 2698-2704, 2016

• DOI för Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
• Ladda ner fulltext (pdf) av Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer

Interpretation of conventional survival analysis and competing-risk analysis: an example of hypertension and prostate cancer

Häggström, Christel; Stattin, Pär; Stocks, Tanja; Garmo, Hans et al.

Ingår i BJU International, s. 850-852, 2016

• DOI för Interpretation of conventional survival analysis and competing-risk analysis: an example of hypertension and prostate cancer
• Ladda ner fulltext (pdf) av Interpretation of conventional survival analysis and competing-risk analysis: an example of hypertension and prostate cancer

Prognostic Implications of 2005 Gleason Grade Modification. Population-Based Study of Biochemical Recurrence Following Radical Prostatectomy

Thomsen, Frederik B.; Folkvaljon, Yasin; Brasso, Klaus; Loeb, Stacy et al.

Ingår i Journal of Surgical Oncology, s. 664-670, 2016

• DOI för Prognostic Implications of 2005 Gleason Grade Modification. Population-Based Study of Biochemical Recurrence Following Radical Prostatectomy

Reply from Authors re: Matthew T. Gettman. Assessing Work Disability After Radical Prostatectomy. Eur Urol 2016;70:72-3 The Challenge of Assessing Work Disability

Plym, Anna; Voss, Margaretha; Stattin, Pär; Lambe, Mats

Ingår i European Urology, s. 73-74, 2016

• DOI för Reply from Authors re: Matthew T. Gettman. Assessing Work Disability After Radical Prostatectomy. Eur Urol 2016;70:72-3 The Challenge of Assessing Work Disability

Dashboard report on performance on select quality indicators to cancer care providers

Stattin, Pär; Sandin, Fredrik; Sandback, Torsten; Damber, Jan-Erik et al.

Ingår i Scandinavian journal of urology, s. 21-28, 2016

• DOI för Dashboard report on performance on select quality indicators to cancer care providers

Immediate versus delayed prostatectomy: Nationwide population-based study

Loeb, Stacy; Folkvaljon, Yasin; Robinson, David; Makarov, Danil V. et al.

Ingår i Scandinavian journal of urology, s. 246-254, 2016

• DOI för Immediate versus delayed prostatectomy: Nationwide population-based study

Risk of malignant melanoma in men with prostate cancer: Nationwide, population-based cohort study

Thomsen, Frederik B.; Folkvaljon, Yasin; Garmo, Hans; Robinson, David et al.

Ingår i International Journal of Cancer, s. 2154-2160, 2016

• DOI för Risk of malignant melanoma in men with prostate cancer: Nationwide, population-based cohort study

The Proteome of Primary Prostate Cancer.

Iglesias-Gato, Diego; Wikström, Pernilla; Tyanova, Stefka; Lavallee, Charlotte et al.

Ingår i European Urology, s. 942-52, 2016

• DOI för The Proteome of Primary Prostate Cancer.

Re: Editorial Comment on Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma

Loeb, Stacy; Lambe, Mats; Stattin, Pär

Ingår i Journal of Urology, s. 1172-1173, 2016

Work Disability After Robot-assisted or Open Radical Prostatectomy: A Nationwide, Population-based Study

Plym, Anna; Chiesa, Flaminia; Voss, Margaretha; Holmberg, Lars et al.

Ingår i European Urology, s. 64-71, 2016

• DOI för Work Disability After Robot-assisted or Open Radical Prostatectomy: A Nationwide, Population-based Study

Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation

O'Farrell, Sean; Sandström, Karin; Garmo, Hans; Stattin, Pär et al.

Ingår i BJU International, s. 391-398, 2016

• DOI för Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation

Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study

Fridriksson, Jon O.; Folkvaljon, Yasin; Nilsson, Per; Robinson, David et al.

Ingår i Scandinavian journal of urology, s. 338-345, 2016

• DOI för Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study
• Ladda ner fulltext (pdf) av Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study

Further Evidence against a Causal Association between Erectile Dysfunction Drugs and Melanoma

Loeb, Stacy; Stattin, Pär

Ingår i European Urology, s. 816-817, 2016

• DOI för Further Evidence against a Causal Association between Erectile Dysfunction Drugs and Melanoma

Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort

Bjartell, Anders; Bottai, Matteo; Persson, Josefin; Bratt, Ola et al.

Ingår i Scandinavian journal of urology, s. 255-259, 2016

• DOI för Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort

Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment

Loeb, Stacy; Folkvaljon, Yasin; Robinson, David; Schlomm, Thorsten et al.

Ingår i European Urology, s. 824-828, 2016

• DOI för Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment

Small bowel obstruction and abdominal pain after robotic versus open radical prostatectomy

Lundström, Karl-Johan; Folkvaljon, Yasin; Loeb, Stacy; Axelson, Anna Bill et al.

Ingår i Scandinavian journal of urology, s. 155-159, 2016

• DOI för Small bowel obstruction and abdominal pain after robotic versus open radical prostatectomy

Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories

Arthur, Rhonda; Møller, Henrik; Garmo, Hans; Holmberg, Lars et al.

Ingår i Cancer Medicine, s. 1307-1318, 2016

• DOI för Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
• Ladda ner fulltext (pdf) av Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories

High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting.

Hammarsten, Peter; Dahl Scherdin, Tove; Hägglöf, Christina; Andersson, Pernilla et al.

Ingår i PLOS ONE, 2016

• DOI för High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting.

Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor Growth.

Halin Bergström, Sofia; Nilsson, Maria; Adamo, Hanibal; Thysell, Elin et al.

Ingår i PLOS ONE, 2016

• DOI för Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor Growth.

The roles of stress and social support in prostate cancer mortality

Jan, Michael; Bonn, Stephanie E; Sjölander, Arvid; Wiklund, Fredrik et al.

Ingår i Scandinavian journal of urology, s. 47-55, 2016

• DOI för The roles of stress and social support in prostate cancer mortality
• Ladda ner fulltext (pdf) av The roles of stress and social support in prostate cancer mortality

Svenska kvalitetsregister slår hål på larmrapporter - Register med stora studiepopulationer ger liten risk för fynd baserade på slump eller förväxling.

Stattin, Pär

Ingår i Läkartidningen, 2016

Snus use, smoking and survival among prostate cancer patients.

Wilson, Kathryn M; Markt, Sarah C; Fang, Fang; Nordenvall, Caroline et al.

Ingår i International Journal of Cancer, s. 2753-2759, 2016

• DOI för Snus use, smoking and survival among prostate cancer patients.

International cancer seminars: a focus on kidney cancer.

Scelo, G; Hofmann, J N; Banks, R E; Bigot, P et al.

Ingår i Annals of Oncology, s. 1382-5, 2016

• DOI för International cancer seminars: a focus on kidney cancer.

Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies.

Allen, Naomi E; Travis, Ruth C; Appleby, Paul N; Albanes, Demetrius et al.

Ingår i Journal of the National Cancer Institute, 2016

• DOI för Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies.

Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls.

Price, Alison J; Travis, Ruth C; Appleby, Paul N; Albanes, Demetrius et al.

Ingår i European Urology, s. 941-951, 2016

• DOI för Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls.

Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer.

Lumme, Sonja; Tenkanen, Leena; Langseth, Hilde; Gislefoss, Randi et al.

Ingår i Acta Oncologica, s. 839-45, 2016

• DOI för Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer.

Clinical characteristics and primary management of patients diagnosed with prostate cancer between 2007 and 2013: status from a Danish primary referral center

Thomsen, Frederik B.; Mikkelsen, Marta K.; Hansen, Rikke B.; Krug, Andrea H. et al.

Ingår i Acta Oncologica, s. 1456-1460, 2016

• DOI för Clinical characteristics and primary management of patients diagnosed with prostate cancer between 2007 and 2013: status from a Danish primary referral center

Proportion and characteristics of men with unknown risk category in the National Prostate Cancer Register of Sweden

Tomic, Katarina; Westerberg, Marcus; Robinson, David; Garmo, Hans et al.

Ingår i Acta Oncologica, s. 1461-1466, 2016

• DOI för Proportion and characteristics of men with unknown risk category in the National Prostate Cancer Register of Sweden

Phosphodiesterase type 5 inhibitors (PDE5i) and prostate cancer recurrence

Loeb, Stacy; Folkvaljon, Yasin; Robinson, David; Schlomm, Thorsten et al.

Ingår i Journal of Clinical Oncology, 2016

Postoperative mortality 90 days after robot-assisted laparoscopic prostatectomy and retropubic radical prostatectomy: a nationwide population-based study

Björklund, Johan; Folkvaljon, Yasin; Cole, Alexander; Carlsson, Stefan et al.

Ingår i BJU International, s. 302-306, 2016

• DOI för Postoperative mortality 90 days after robot-assisted laparoscopic prostatectomy and retropubic radical prostatectomy: a nationwide population-based study

A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

Travis, Ruth C.; Appleby, Paul N.; Martin, Richard M.; Holly, Jeff M. P. et al.

Ingår i Cancer Research, s. 2288-2300, 2016

• DOI för A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort

Loeb, Stacy; Folkvaljon, Yasin; Robinson, David; Lissbrant, Ingela Franck et al.

Ingår i European Urology, s. 1135-1141, 2016

• DOI för Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort

5-alpha reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer

Robinson, David; Garmo, Hans; Holmberg, Lars; Stattin, Pär

Ingår i Cancer Causes and Control, s. 1289-1297, 2015

• DOI för 5-alpha reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer
• Ladda ner fulltext (pdf) av 5-alpha reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer

An investigation into the relationship between Statins and Cancer using population-based data

Melvin, Jennifer C; Garmo, Hans; Daniel, Rhian; Shanmugalingam, Thurkaa et al.

Ingår i BJU International, s. 681-683, 2015

• DOI för An investigation into the relationship between Statins and Cancer using population-based data

How to model temporal changes in comorbidity for cancer patients using prospective cohort data

Lindhagen, Lars; Van Hemelrijck, Mieke; Robinson, David; Stattin, Pär et al.

Ingår i BMC Medical Informatics and Decision Making, 2015

• DOI för How to model temporal changes in comorbidity for cancer patients using prospective cohort data
• Ladda ner fulltext (pdf) av How to model temporal changes in comorbidity for cancer patients using prospective cohort data

Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study

Robinson, David; Garmo, Hans; Stattin, Pär; Michaëlsson, Karl

Ingår i PLOS ONE, 2015

• DOI för Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study
• Ladda ner fulltext (pdf) av Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study

Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer

O'Farrell, Sean; Garmo, Hans; Holmberg, Lars; Adolfsson, Jan et al.

Ingår i Journal of Clinical Oncology, s. 1243-1251, 2015

• DOI för Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer

Five-year Nationwide Follow-up Study of Active Surveillance for Prostate Cancer

Loeb, Stacy; Folkvaljon, Yasin; Makarov, Danil V.; Bratt, Ola et al.

Ingår i European Urology, s. 233-238, 2015

• DOI för Five-year Nationwide Follow-up Study of Active Surveillance for Prostate Cancer

ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)

Markt, Sarah C; Shui, Irene M; Unger, Robert H; Urun, Yuksel et al.

Ingår i The Prostate, s. 1677-81, 2015

• DOI för ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)
• Ladda ner fulltext (pdf) av ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)

Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer

Bratt, Ola; Folkvaljon, Yasin; Eriksson, Marie Hjalm; Akre, Olof et al.

Ingår i European Urology, s. 53-58, 2015

• DOI för Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer
• Ladda ner fulltext (pdf) av Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer

Capture rate and representativity of The National Prostate Cancer Register of Sweden

Tomic, Katarina; Berglund, Anders; Robinson, David; Hjälm-Eriksson, Marie et al.

Ingår i Acta Oncologica, s. 158-163, 2015

• DOI för Capture rate and representativity of The National Prostate Cancer Register of Sweden
• Ladda ner fulltext (pdf) av Capture rate and representativity of The National Prostate Cancer Register of Sweden

Gleason inflation 1998-2011: a registry study of 97,168 men

Danneman, Daniela; Drevin, Linda; Robinson, David; Stattin, Pär et al.

Ingår i BJU International, s. 248-55, 2015

• DOI för Gleason inflation 1998-2011: a registry study of 97,168 men
• Ladda ner fulltext (pdf) av Gleason inflation 1998-2011: a registry study of 97,168 men

Correlation of Gleason Score in Biopsy and Radical Prostatectomy Specimens 2000-2012-A Registry Study of 15598 Men

Egevad, Lars; Danneman, Daniela; Stattin, Pär; Drevin, Linda

Ingår i Laboratory Investigation, 2015

Re: Giorgio Gandaglia, Freddie Bray, Matthew R. Cooperberg, et al. Prostate Cancer Registries: Current Status and Future Directions. Eur Urol 2015;68:e110

Stattin, Pär; Robinson, David; Lambe, Mats

Ingår i European Urology, 2015

• DOI för Re: Giorgio Gandaglia, Freddie Bray, Matthew R. Cooperberg, et al. Prostate Cancer Registries: Current Status and Future Directions. Eur Urol 2015;68:e110

Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions.

Lundholm, Marie; Hägglöf, Christina; Wikberg, Maria L; Stattin, Pär et al.

Ingår i Scientific Reports, 2015

• DOI för Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions.

High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting

Nilsson, Maria; Hägglöf, Christina; Hammarsten, Peter; Thysell, Elin et al.

Ingår i PLOS ONE, 2015

• DOI för High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting
• Ladda ner fulltext (pdf) av High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting

Evaluation of data quality in the National Prostate Cancer Register of Sweden

Tomic, Katarina; Sandin, Fredrik; Wigertz, Annette; Robinson, David et al.

Ingår i European Journal of Cancer, s. 101-111, 2015

• DOI för Evaluation of data quality in the National Prostate Cancer Register of Sweden

Physical activity and survival among men diagnosed with prostate cancer

Bonn, Stephanie E; Sjölander, Arvid; Lagerros, Ylva Trolle; Wiklund, Fredrik et al.

Ingår i Cancer Epidemiology, Biomarkers and Prevention, s. 57-64, 2015

• DOI för Physical activity and survival among men diagnosed with prostate cancer

Metabolic risk score and cancer risk: pooled analysis of seven cohorts

Stocks, Tanja; Bjørge, Tone; Ulmer, Hanno; Manjer, Jonas et al.

Ingår i International Journal of Epidemiology, s. 1353-1363, 2015

• DOI för Metabolic risk score and cancer risk: pooled analysis of seven cohorts
• Ladda ner fulltext (pdf) av Metabolic risk score and cancer risk: pooled analysis of seven cohorts

Associations Do Not Equal Causation: Clinical Relevance of Statistical Associations of Phosphodiesterase Type 5 Inhibitors with Prostate Cancer Progression and Melanoma.

Loeb, Stacy; Schlomm, Thorsten; Stattin, Pär

Ingår i European Urology, s. 754-755, 2015

• DOI för Associations Do Not Equal Causation: Clinical Relevance of Statistical Associations of Phosphodiesterase Type 5 Inhibitors with Prostate Cancer Progression and Melanoma.

Insufficient Sleep and Risk of Prostate Cancer in a Large Swedish Cohort.

Markt, Sarah C; Grotta, Alessandra; Nyren, Olof; Adami, Hans-Olov et al.

Ingår i Sleep, s. 1405-10, 2015

• DOI för Insufficient Sleep and Risk of Prostate Cancer in a Large Swedish Cohort.

Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study

Stattin, Pär; Vickers, Andrew J; Sjoberg, Daniel D; Johansson, Robert et al.

Ingår i European Urology, s. 207-213, 2015

• DOI för Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study

Physical activity and body mass index as predictors of prostate cancer risk

Grotta, Alessandra; Bottai, Matteo; Adami, Hans-Olov; Adams, Swann Arp et al.

Ingår i World journal of urology, s. 1495-1502, 2015

• DOI för Physical activity and body mass index as predictors of prostate cancer risk

Mortality in older men with low-risk prostate cancer and high comorbidity

Stattin, Pär

Ingår i Journal of Clinical Oncology, s. 1086-1087, 2015

• DOI för Mortality in older men with low-risk prostate cancer and high comorbidity

Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition

Tsilidis, Konstantinos K; Allen, Naomi E; Appleby, Paul N; Rohrmann, Sabine et al.

Ingår i International Journal of Cancer, s. 372-81, 2015

• DOI för Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition
• Ladda ner fulltext (pdf) av Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition

Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma

Loeb, Stacy; Folkvaljon, Yasin; Lambe, Mats; Robinson, David et al.

Ingår i Journal of the American Medical Association (JAMA), s. 2449-2455, 2015

• DOI för Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma

Upper limit of cancer extent on biopsy defining very low-risk prostate cancer

Bratt, Ola; Folkvaljon, Yasin; Loeb, Stacy; Klotz, Laurence et al.

Ingår i BJU International, s. 213-219, 2015

• DOI för Upper limit of cancer extent on biopsy defining very low-risk prostate cancer

Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples.

Jonsson, Pär; Wuolikainen, Anna; Thysell, Elin; Chorell, Elin et al.

Ingår i Metabolomics, s. 1667-1678, 2015

• DOI för Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples.
• Ladda ner fulltext (pdf) av Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples.

Incidence of groin hernia repair after radical prostatectomy: a population-based nationwide study.

Nilsson, Hanna; Stranne, Johan; Stattin, Pär; Nordin, Pär

Ingår i Annals of Surgery, s. 1223-1227, 2014

• DOI för Incidence of groin hernia repair after radical prostatectomy: a population-based nationwide study.

"To measure is to know. If you cannot measure it, you cannot improve it": Statistical modeling cannot compensate for unmeasured bias

Stattin, Pär; Loeb, Stacy

Ingår i European Urology, s. 701-703, 2014

• DOI för "To measure is to know. If you cannot measure it, you cannot improve it": Statistical modeling cannot compensate for unmeasured bias

Prostate cancer mortality in areas with high and low prostate cancer incidence

Stattin, Pär; Carlsson, Sigrid; Holmström, Benny; Vickers, Andrew et al.

Ingår i Journal of the National Cancer Institute, 2014

• DOI för Prostate cancer mortality in areas with high and low prostate cancer incidence
• Ladda ner fulltext (pdf) av Prostate cancer mortality in areas with high and low prostate cancer incidence

Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project

Lindkvist, Björn; Johansen, Dorthe; Stocks, Tanja; Concin, Hans et al.

Ingår i BMC Cancer, s. 103, 2014

• DOI för Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project

TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers.

Hägglöf, Christina; Hammarsten, Peter; Strömvall, Kerstin; Egevad, Lars et al.

Ingår i PLOS ONE, 2014

• DOI för TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers.
• Ladda ner fulltext (pdf) av TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers.

Fathering of Dizygotic Twins and Risk of Prostate Cancer: Nationwide, Population-Based Case-Control Study

Wiren, Sara; Drevin, Linda; Akre, Olof; Robinson, David et al.

Ingår i PLOS ONE, 2014

• DOI för Fathering of Dizygotic Twins and Risk of Prostate Cancer: Nationwide, Population-Based Case-Control Study

A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study

Borena, Wegene; Edlinger, Michael; Bjørge, Tone; Häggström, Christel et al.

Ingår i PLOS ONE, 2014

• DOI för A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study

Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

Wang, Zhaoming; Zhu, Bin; Zhang, Mingfeng; Parikh, Hemang et al.

Ingår i Human Molecular Genetics, s. 6616-6633, 2014

• DOI för Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

Pooled cohort study on height and risk of cancer and cancer death

Wirén, Sara; Häggström, Christel; Ulmer, Hanno; Manjer, Jonas et al.

Ingår i Cancer Causes and Control, s. 151-159, 2014

• DOI för Pooled cohort study on height and risk of cancer and cancer death

High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.

Tidehag, Viktor; Hammarsten, Peter; Egevad, Lars; Granfors, Torvald et al.

Ingår i European Journal of Cancer, s. 1829-1835, 2014

• DOI för High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.

Body mass index and weight change in men with prostate cancer: progression and mortality.

Bonn, Stephanie E; Wiklund, Fredrik; Sjölander, Arvid; Szulkin, Robert et al.

Ingår i Cancer Causes and Control, s. 933-943, 2014

• DOI för Body mass index and weight change in men with prostate cancer: progression and mortality.

Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations

Häggström, Christel; Stocks, Tanja; Nagel, Gabriele; Manjer, Jonas et al.

Ingår i Epidemiology, s. 823-828, 2014

• DOI för Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations

Response

Stattin, Pär; Carlsson, Sigrid; Jonsson, Håkan

Ingår i Journal of the National Cancer Institute, 2014

• DOI för Response
• Ladda ner fulltext (pdf) av Response

Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.

Crowe, Francesca L; Appleby, Paul N; Travis, Ruth C; Barnett, Matt et al.

Ingår i Journal of the National Cancer Institute, 2014

• DOI för Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.
• Ladda ner fulltext (pdf) av Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.

Population Based Study of Predictors of Adverse Pathology among Candidates for Active Surveillance with Gleason 6 Prostate Cancer

Vellekoop, Annelies; Loeb, Stacy; Folkvaljon, Yasin; Stattin, Pär

Ingår i Journal of Urology, s. 350-357, 2014

• DOI för Population Based Study of Predictors of Adverse Pathology among Candidates for Active Surveillance with Gleason 6 Prostate Cancer

The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries

Beckmann, Kerri; Garmo, Hans; Franck Lissbrant, Ingela; Stattin, Pär

Ingår i Cancers, 2021

• DOI för The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries
• Ladda ner fulltext (pdf) av The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries

Mini Review on the Use of Clinical Cancer Registers for Prostate Cancer: The National Prostate Cancer Register (NPCR) of Sweden

Cazzaniga, Walter; Ventimiglia, Eugenio; Alfano, Massimo; Robinson, David et al.

Ingår i Frontiers in Medicine, 2019

• DOI för Mini Review on the Use of Clinical Cancer Registers for Prostate Cancer: The National Prostate Cancer Register (NPCR) of Sweden
• Ladda ner fulltext (pdf) av Mini Review on the Use of Clinical Cancer Registers for Prostate Cancer: The National Prostate Cancer Register (NPCR) of Sweden

Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review

Kinsella, Netty; Stattin, Pär; Cahill, Declan; Brown, Christian et al.

Ingår i European Urology, s. 261-280, 2018

• DOI för Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review

A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus

Crawley, Danielle; Chamberlain, Florence; Garmo, Hans; Rudman, Sarah et al.

Ingår i ecancermedicalscience, 2018

• DOI för A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus
• Ladda ner fulltext (pdf) av A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus

Different assumptions about missingness in registration of metastatic status have important implications for following trends in cancer presentation

Westerberg, Marcus; Beckman, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.